IRDI Capital Investissement
Also known as IRDI, IRDI SORIDEC Gestion, Irdi Capital-Investissement
Toulouse-based AMF-authorised private equity manager (GP-15000023) investing €200k–€15M in start-ups, SMEs and mid-caps in Occitanie and Nouvelle-Aquitaine; €550M under management (Oct 2026).
- HEADQUARTERS
- Toulouse, France
- FOUNDED
- 2015
- AUM
- €550M (2026)
- OUTSIDE CAPITAL
- Yes
- TEAM LISTED
- 12 people
Focus
- STAGES
- SeedSeries AGrowthBuyout
- SECTORS
- Industrial & ManufacturingSpaceHealthTechSoftware & SaaSBiotech & Life SciencesClimate & Energy
- ASSET MIX
- Private equityVenture capital
- GEOGRAPHY
- France
Overview
IRDI Capital Investissement is a portfolio management company authorised by the AMF that invests equity in start-ups, SMEs and mid-caps in south-west France, from seed to development, transmission and turnaround (“rebond”). It descends from IRDI (created 1981) and SORIDEC (1984), whose management was brought together in 2015 in IRDI SORIDEC Gestion. It has offices in Toulouse, Montpellier and Bordeaux, a team of 29 including 21 investment professionals, and states it manages about €550M through 14 funds, two of them evergreen. Its fund subscribers include the Occitanie and Nouvelle-Aquitaine regions, Bpifrance, regional banks, industrial groups and private investors.
Investment thesis
Regional generalist: seed and venture funds (IRDInov, Aelis Innovation, Inn’Vest PME) for deeptech and digital start-ups with €250k–€3M tickets; proximity development capital for regional SMEs (IRDI Capital Croissance, €200k–€1M, minority); development and transmission/LBO deals (IRDI/SORIDEC, IRDI B, €500k–€15M); and turnaround capital for established companies hit by the economic context (IRDI Impulsion, €500k–€4M equity and quasi-equity).
PORTFOLIO (14)
- Micropep TechnologiesNOTABLEFood & Agriculture · since 2018
- TreeFrog TherapeuticsNOTABLEBiotech & Life Sciences
- STELECIndustrial & Manufacturing · since 2026
- IOPOLEFintech · since 2026
- Viraj AeroSpace · since 2026
- ArcSpaceSpace · since 2026
- Nexteam GroupIndustrial & Manufacturing · since 2026
- Groupe AymardFood & Agriculture · since 2026
- ThIA Santé MentaleHealthTech · since 2026
- DonecleArtificial Intelligence · since 2026
- 3AS RacingConsumer & E-commerce · since 2026
- SphereaIndustrial & Manufacturing · since 2025
- KallistoIndustrial & Manufacturing · since 2025
- Infinite OrbitsSpace · since 2024
People
- Corinne d’AgrainPrésidente du Directoire · source
- Philippe RobardeyPrésident du Conseil de Surveillance · source
- Bertrand ReligieuxMembre du Directoire · source
- Karine FrançoisMembre du Directoire, Secrétaire Générale · source
- Alexandre SchererMembre du Directoire / Directeur d’Investissement · source
- Geneviève BlancDirectrice Associée Amorçage · source
- Jean-Michel PetitDirecteur Associé Amorçage · source
- Julien Sainte-CatherineDirecteur Associé Innovation · source
- Éric CandelierDirecteur Associé Développement Transmission · source
- Étienne RobequainDirecteur Associé Développement Transmission · source
- Nathalie TrioletDirectrice Associée Développement Transmission · source
- Sophie JuéryDirectrice Associée Proximité · source
Links
Frequently asked questions
IRDI Capital Investissement is a private equity fund based in Toulouse, France, founded in 2015.
Yes. IRDI Capital Investissement invests its own capital in private companies.
IRDI Capital Investissement invests at Seed, Series A, Growth and Buyout stages in Industrial & Manufacturing, Space, HealthTech, Software & SaaS, Biotech & Life Sciences and Climate & Energy.
IRDI Capital Investissement's stated ticket size is €200K–€15M.
Key people at IRDI Capital Investissement include Corinne d’Agrain (Présidente du Directoire), Philippe Robardey (Président du Conseil de Surveillance), Bertrand Religieux (Membre du Directoire) and Karine François (Membre du Directoire, Secrétaire Générale).
IRDI Capital Investissement's investments include Micropep Technologies, TreeFrog Therapeutics, STELEC, IOPOLE, Viraj Aero, ArcSpace, Nexteam Group and Groupe Aymard, among others.
The most recent publicly reported investment by IRDI Capital Investissement is STELEC (Takeover (reprise) by Yann Gimmig, completed July 2026; equity via IRDI Capital Croissance alongside Tarn Capital Investissement), announced in Oct 2026.
Yes. IRDI Capital Investissement manages capital from outside investors.